OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 18, 2020
The expansion will be designed to meet the growing demand for small molecule drug substance development and manufacturing.
October 19, 2020
The lab, which is currently available to customers, can handle highly potent compounds.
August 03, 2020
Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.
June 04, 2020
CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.
Agreements with the PolyPeptide Group and AGC Biologics will scale up production of the Novavax Matrix-M adjuvant.
May 19, 2020
HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.
May 06, 2020
CMO Evonik begins capacity expansion of APIs and intermediates at its sites in Dossenheim and Hanau Germany to increase EU supply security for drug products.
May 04, 2020
FDA approved hydroxychloroquine sulfate for emergency use as a treatment for some hospitalized patients with COVID-19.
April 23, 2020
Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.
December 06, 2019
Cambrex reports that the acquisition by the investment group will facilitate ongoing growth.